A new publication referencing macimorelin was published on July 1, 2026. The article, titled "Facts and news about growth hormone replacement therapy in adults," appeared in the journal Annales d'endocrinologie.
This entry reflects the addition of the publication to the scientific literature record under the identifier 41912009. The listing confirms the title, journal, and publication date as provided in the source record.
No findings, conclusions, or data from the publication are summarized here. Readers interested in the full content and any reported results should consult the original article directly through the journal or the linked PubMed record.
Macimorelin remains an approved compound, and this publication is noted here solely as a record of its appearance in current endocrinology literature. For general background on macimorelin, readers can consult the compound overview.